199 related articles for article (PubMed ID: 10696088)
1. The insulinotropic mechanism of the novel hypoglycaemic agent JTT-608: direct enhancement of Ca(2+) efficacy and increase of Ca(2+) influx by phosphodiesterase inhibition.
Mukai E; Ishida H; Fujimoto S; Kajikawa M; Okamoto Y; Fujita J; Hamamoto Y; Tsuura Y; Yamada Y; Furukawa N; Ohta T; Seino Y
Br J Pharmacol; 2000 Mar; 129(5):901-8. PubMed ID: 10696088
[TBL] [Abstract][Full Text] [Related]
2. A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism.
Itabashi N; Okada K; Muto S; Fujita N; Ohta T; Miyazaki Ji ; Asano Y; Saito T
J Pharmacol Exp Ther; 2001 Jun; 297(3):953-60. PubMed ID: 11356916
[TBL] [Abstract][Full Text] [Related]
3. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
Shafiee-Nick R; Pyne NJ; Furman BL
Br J Pharmacol; 1995 Aug; 115(8):1486-92. PubMed ID: 8564209
[TBL] [Abstract][Full Text] [Related]
4. A new hypoglycemic agent, JTT-608, evokes protein kinase A-mediated Ca(2+) signaling in rat islet beta-cells: strict regulation by glucose, link to insulin release, and cooperation with glucagon-like peptide-1(7-36)amide and pituitary adenylate cyclase-activating polypeptide.
Hashiguchi S; Yada T; Arima T
J Pharmacol Exp Ther; 2001 Jan; 296(1):22-30. PubMed ID: 11123358
[TBL] [Abstract][Full Text] [Related]
5. Glucose-dependent insulinotropic effects of JTT-608, a novel antidiabetic compound.
Furukawa N; Ohta T; Noguchi T; Yonemori F; Wakitani K
Eur J Pharmacol; 1999 Apr; 371(1):51-8. PubMed ID: 10355594
[TBL] [Abstract][Full Text] [Related]
6. The novel insulinotropic mechanism of pimobendan: direct enhancement of the exocytotic process of insulin secretory granules by increased Ca2+ sensitivity in beta-cells.
Fujimoto S; Ishida H; Kato S; Okamoto Y; Tsuji K; Mizuno N; Ueda S; Mukai E; Seino Y
Endocrinology; 1998 Mar; 139(3):1133-40. PubMed ID: 9492047
[TBL] [Abstract][Full Text] [Related]
7. JTT-608 controls blood glucose by enhancement of glucose-stimulated insulin secretion in normal and diabetes mellitus rats.
Ohta T; Furukawa N; Yonemori F; Wakitani K
Eur J Pharmacol; 1999 Feb; 367(1):91-9. PubMed ID: 10082270
[TBL] [Abstract][Full Text] [Related]
8. A novel D-phenylalanine-derivative hypoglycemic agent A-4166 increases cytosolic free Ca2+ in rat pancreatic beta-cells by stimulating Ca2+ influx.
Fujitani S; Yada T
Endocrinology; 1994 Mar; 134(3):1395-400. PubMed ID: 8119179
[TBL] [Abstract][Full Text] [Related]
9. JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats.
Ohta T; Furukawa N; Komuro G; Yonemori F; Wakitani K
Br J Pharmacol; 1999 Apr; 126(7):1674-80. PubMed ID: 10323602
[TBL] [Abstract][Full Text] [Related]
10. Dependency of cyclic AMP-induced insulin release on intra- and extracellular calcium in rat islets of Langerhans.
Siegel EG; Wollheim CB; Kikuchi M; Renold AE; Sharp GW
J Clin Invest; 1980 Feb; 65(2):233-41. PubMed ID: 6153182
[TBL] [Abstract][Full Text] [Related]
11. A new experimental model of ATP-sensitive K⁺ channel-independent insulinotropic action of glucose: a permissive role of cAMP for triggering of insulin release from rat pancreatic β-cells.
Takei M; Dezaki K; Ishii H; Nishio S; Sato Y; Suzuki S; Yada T; Komatsu M
Endocr J; 2013; 60(5):599-607. PubMed ID: 23327802
[TBL] [Abstract][Full Text] [Related]
12. Interacting effects of sulfonylureas and glucose on cyclic AMP metabolism and insulin release in pancreatic islets of the rat.
Grill V; Cerasi E
J Clin Invest; 1978 May; 61(5):1346-54. PubMed ID: 207736
[TBL] [Abstract][Full Text] [Related]
13. Tambulin from Zanthoxylum armatum acutely potentiates the glucose-induced insulin secretion via K
Hameed A; Raza SA; Israr Khan M; Baral J; Adhikari A; Nur-E-Alam M; Ahmed S; Al-Rehaily AJ; Ashraf S; Ul-Haq Z; Hafizur RM
Biomed Pharmacother; 2019 Dec; 120():109348. PubMed ID: 31629954
[TBL] [Abstract][Full Text] [Related]
14. Distinct effect of diazoxide on insulin secretion stimulated by protein kinase A and protein kinase C in rat pancreatic islets.
Shen ZP; Nishimura M; Tsuura Y; Fujimoto S; Mukai E; Yamada Y; Seino Y
Diabetes Res Clin Pract; 2001 Jul; 53(1):9-16. PubMed ID: 11378208
[TBL] [Abstract][Full Text] [Related]
15. Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine (A-4166).
Ikenoue T; Akiyoshi M; Fujitani S; Okazaki K; Kondo N; Maki T
Br J Pharmacol; 1997 Jan; 120(1):137-45. PubMed ID: 9117089
[TBL] [Abstract][Full Text] [Related]
16. 4-(trans-4-Methylcyclohexyl)-4-oxobutyric acid (JTT-608). A new class of antidiabetic agent.
Shinkai H; Ozeki H; Motomura T; Ohta T; Furukawa N; Uchida I
J Med Chem; 1998 Dec; 41(27):5420-8. PubMed ID: 9876112
[TBL] [Abstract][Full Text] [Related]
17. Tolbutamide and diazoxide modulate phospholipase C-linked Ca(2+) signaling and insulin secretion in beta-cells.
Schöfl C; Börger J; Mader T; Waring M; von zur Mühlen A; Brabant G
Am J Physiol Endocrinol Metab; 2000 Apr; 278(4):E639-47. PubMed ID: 10751197
[TBL] [Abstract][Full Text] [Related]
18. Effect of type-selective inhibitors on cyclic nucleotide phosphodiesterase activity and insulin secretion in the clonal insulin secreting cell line BRIN-BD11.
Ahmad M; Abdel-Wahab YH; Tate R; Flatt PR; Pyne NJ; Furman BL
Br J Pharmacol; 2000 Mar; 129(6):1228-34. PubMed ID: 10725272
[TBL] [Abstract][Full Text] [Related]
19. ACTH stimulates insulin secretion from MIN6 cells and primary mouse and human islets of Langerhans.
Al-Majed HT; Jones PM; Persaud SJ; Sugden D; Huang GC; Amiel S; Whitehouse BJ
J Endocrinol; 2004 Jan; 180(1):155-66. PubMed ID: 14709154
[TBL] [Abstract][Full Text] [Related]
20. The possible mechanisms by which phanoside stimulates insulin secretion from rat islets.
Hoa NK; Norberg A; Sillard R; Van Phan D; Thuan ND; Dzung DT; Jörnvall H; Ostenson CG
J Endocrinol; 2007 Feb; 192(2):389-94. PubMed ID: 17283239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
